-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Navidea Biopharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q4 2019 to Q3 2023.
- Navidea Biopharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending September 30, 2023 was $1.36K, a 93.1% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)